Maintenance of parenteral nutrition volume reduction, without weight loss, after stopping teduglutide in a subset of patients with short bowel syndrome

Journal of Parenteral and Enteral Nutrition

Volumn 35, Issue 5, 2011, Pages 603-609

  Compher, Charlene ^a   Gilroy, Richard ^b   Pertkiewicz, Marek ^c   Ziegler, Thomas R ^d   Ratcliffe, Sarah J ^e   Joly, Francisca ^f   Rochling, Fedja ^g   Messing, Bernard ^f  

^a UNIVERSITY OF PENNSYLVANIA SCHOOL OF NURSING   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f BEAUJON HOSPITAL   (France)

^g UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

glucagon like peptide 2; intestinal failure; parenteral nutrition; short bowel syndrome; teduglutide

Indexed keywords

TEDUGLUTIDE;

ADULT; AGED; ARTICLE; BODY MASS; COLON; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PARENTERAL NUTRITION; PRIORITY JOURNAL; SHORT BOWEL SYNDROME; SMALL INTESTINE; TREATMENT RESPONSE; WEIGHT REDUCTION;

ADULT; AGED; BODY MASS INDEX; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTESTINE, SMALL; LINEAR MODELS; MALE; MIDDLE AGED; PARENTERAL NUTRITION; PEPTIDES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SHORT BOWEL SYNDROME; TREATMENT OUTCOME; WEIGHT LOSS; YOUNG ADULT;

EID: 80052369859     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607111414431     Document Type: Article

References (15)

1. Chan S, McCowen KC, Bistrian BR, et al. Incidence, prognosis, and etiology of end-stage liver disease in patients receiving home total parenteral nutrition. Surgery. 1999 ; 126 (1). 28-34 (Pubitemid 29340688)
2. Cavicchi M, Beau P, Crenn P, Degott C, Messing B. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med. 2000 ; 132 (7). 525-532 (Pubitemid 30171891)
3. Salvino R, Ghanta R, Seidner DL, Mascha E, Xu Y, Steiger E. Liver failure is uncommon in adults receiving long-term parenteral nutrition. JPEN Parenter Enteral Nutr. 2006 ; 30: 202-208
4. Pironi L, Joly F, Forbes A, et al. Long-term follow-up on patients on home parenteral nutrition in Europe: implications for intestinal transplantation. Gut. 2011 ; 60: 17-25
5. Haderslev KV, Tjellesen L, Haderslev PH, Staun M. Assessment of the longitudinal changes in bone mineral density in patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr. 2004 ; 28 (5). 289-294 (Pubitemid 39121448)
6. Buchman AL. Complications of long-term home total parenteral nutrition: their identification, prevention and treatment. Dig Dis Sci. 2001 ; 46 (1). 1-18 (Pubitemid 32221832)
7. O'Keefe SJ, Buchman AL, Fishbein TM, Jeejeebhoy KN, Jeppesen PB, Shaffer J. Short bowel syndrome and intestinal failure: consensus definitions and overview. Clin Gastroenterol Hepatol. 2006 ; 4: 6-10 (Pubitemid 43129518)
8. Hyltander A, Bosaeus I, Svedlund J, et al. Supportive nutrition on recovery of metabolism, nutritional state, health-related quality of life, and exercise capacity after major surgery: a randomized study. Clin Gastroenterol Hepatol. 2005 ; 3 (5). 466-474 (Pubitemid 40616912)
9. Jeppesen PB, Gilroy R, Pertkiewicz M, Allard JP, Messing M, O'Keefe SJ. A randomized placebo-controlled clinical trial of teduglutide in reducing parenteral nutrition infusions in short bowel syndrome patients. Gut. 2011 ;:
10. DiBaise JK, Matarese LE, Messing B, Steiger E. Strategies for parenteral nutrition weaning in adult patients with short bowel syndrome. J Clin Gastroenterol. 2006 ; 40: S94 - S99
11. Messing B, Crenn P, Beau P, Boutron-Ruault MC, Rambaud JC, Matuchansky C. Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology. 1999 ; 117 (5). 1043-1050 (Pubitemid 29512662)
12. Crenn P, Coudray-Lucas C, Thuillier F, Cynober L, Messing B. Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology. 2000 ; 119: 1496-1505 (Pubitemid 32198675)
13. Jeppesen PB, Hartmann B, Thulesen J, et al. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology. 2001 ; 120: 806-815 (Pubitemid 32193176)
14. Jeppesen PB, Sanguinetti EL, Buchman A, et al. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut. 2005 ; 54: 1224-1231 (Pubitemid 41192479)
15. Jeppesen PB, Lund P, Gottschalck IB, et al. Short bowel patients treated for two years with glucagon-like peptide 2: effects on intestinal morphology and absorption, renal function, bone and body composition, and muscle function. Gastroenterol Res Pract. :